The MAPK Pathway as a Therapeutic Target in Cancer Research

Article   Nov 30, 2017 | by Jack Rudd, Senior Editor for Technology Networks

 
The MAPK Pathway as a Therapeutic Target in Cancer Research

Jack Rudd

Managing Editor

 
 
 

RELATED ARTICLES

One Year on, Scientists Defend Canada’s Anti-Genetic Discrimination Law

Article

The Canadian Genetic Non-Discrimination Act (GNA), introduced last May, made it illegal to require individuals to disclose genetic test results or to compel individuals to undergo genetic tests for any agreement or service. However, a subsequent legal challenge has prompted a robust defense of the act from scientists in the May issue of the Canadian Medical Association Journal (CMAJ).

READ MORE

Novel Collagen Membrane Improves Colon-on-a-Chip Functionality

Article

A microfluidic model of the colon has been built using natural tissue base matrix, which closely mimics the structure and function of the colon.

READ MORE

Henrietta Lacks: The Mother of Modern Medicine

Article

A portrait of Henrietta Lacks has recently been unveiled at the Smithsonian’s National Portrait Gallery, to recognize her life and the vital contributions HeLa cells have made to science.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy